We are live on ! Find out more
CPRX

Catalyst Pharmaceutical
CPRX

Delisted

CPRX was delisted on the 14th of July, 2026.

Back to rankings

88 hedge funds and large institutions have $314M invested in Catalyst Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

232% more capital invested

Capital invested by funds: $94.3M → $314M (+$219M)

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

12.03% more ownership

Funds ownership: 47.83% → 59.85% (+12%)

2% more funds holding

Funds holding: 86 → 88 (+2)

7% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 27

43% less call options, than puts

Call options by funds: $683K | Put options by funds: $1.19M

Holders
88
Holders Change
+2
Holders Change %
+2.33%
% of All Funds
1.9%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.06%
New
15
Increased
25
Reduced
27
Closed
13
Calls
$683K
Puts
$1.19M
Net Calls
-$505K
Net Calls Change
-$424K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$24.9M
2
OM
Opaleye Management
Massachusetts
+$5.36M
3
MP
Mangrove Partners
Connecticut
+$3.2M
4
KCM
Kennedy Capital Management
Missouri
+$2.94M
5
HRCM
Hawk Ridge Capital Management
California
+$1.93M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$2.76M
2
BC
Broadfin Capital
New York
-$1.21M
3
PAM
Panagora Asset Management
Massachusetts
-$920K
4
DMK
David M. Knott
-$302K
5
IG
ING Group
Netherlands
-$271K
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
51
Los Angeles Capital Management
California
$218K – – –
II
52
Ibex Investors
Colorado
$215K +$124K +42,098 New
VOYA Investment Management
53
VOYA Investment Management
Georgia
$210K – – –
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$202K -$50.5K -17,168 -30%
Commonwealth Equity Services
55
Commonwealth Equity Services
Massachusetts
$146K +$2.94K +1,000 +4%
Simplex Trading
56
Simplex Trading
Illinois
$145K +$75.1K +25,542 +853%
MLICM
57
Metropolitan Life Insurance Company (MetLife)
New York
$144K +$3.02K +1,028 +4%
Barclays
58
Barclays
United Kingdom
$139K +$76.8K +26,127 +2,304%
FAAS
59
First Allied Advisory Services
California
$138K – – –
Citigroup
60
Citigroup
New York
$134K +$2.45K +833 +3%
TSS
61
Two Sigma Securities
New York
$126K +$72.4K +24,645 New
Bank of America
62
Bank of America
North Carolina
$125K -$50.2K -17,077 -41%
CS
63
Credit Suisse
Switzerland
$110K +$18.7K +6,365 +42%
FIA
64
FNY Investment Advisers
New York
$104K +$60.3K +20,500 New
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$102K +$58.9K +20,042 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$102K – – –
AWS
67
AJ Wealth Strategies
New York
$99K – – –
PMG
68
ProVise Management Group
Florida
$97K – – –
BCA
69
Biltmore Capital Advisors
New Jersey
$79K +$45.3K +15,400 New
Citadel Advisors
70
Citadel Advisors
Florida
$78K -$164K -55,875 -78%
AB
71
Amalgamated Bank
New York
$77K +$1.47K +499 +3%
Legal & General Group
72
Legal & General Group
United Kingdom
$75K – – –
RJA
73
Raymond James & Associates
Florida
$66K -$5.88K -2,000 -13%
Principal Financial Group
74
Principal Financial Group
Iowa
$66K -$5.19K -1,766 -12%
WG
75
Winton Group
United Kingdom
$64K +$36.6K +12,454 New
1 2
3
4 5

CPRX Hedge Fund Activity: Q1 2019 in Review

88 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q1 2019, worth a combined $314M — up 232% from $94.3M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CPRX positions and 13 closed out — a net gain of 2 holders — while 25 added to existing stakes and 27 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $24.9M. The largest seller was Morgan Stanley, cutting an estimated $2.76M.

  • 88 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q1 2019, up from 86 in Q4 2018.
  • Funds reported $314M of Catalyst Pharmaceutical stock for Q1 2019, up 232% quarter-over-quarter.
  • 15 funds opened new Catalyst Pharmaceutical positions in Q1 2019 and 13 closed out, a net change of +2 holders.
  • The largest Catalyst Pharmaceutical buyer in Q1 2019 was Consonance Capital Management, an estimated $24.9M added.
  • The largest Catalyst Pharmaceutical seller in Q1 2019 was Morgan Stanley, an estimated $2.76M sold.

Based on aggregated 13F filings for Q1 2019.